Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Sumitomo Pharma Co. Ltd. ADR - 865614101 (OTCMKTS : SMDPY ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quote
| Last: | $11.7501 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $11.7501 |
| Close: | $11.7501 |
| High: | $11.7501 |
| Low: | $11.7501 |
| Volume: | 100 |
| Last Trade Date Time: | 04/07/2026 09:30:00 am |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Sumitomo Pharma Co. Ltd. ADR - 865614101 (OTCMKTS: SMDPY).
